Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Barrett Esophagus × X-Rays × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Wilms Tumor 7 Neuroblastoma 7 Lymphoma, Non-Hodgkin 7 Hepatoblastoma 7 Colorectal Neoplasms 7 Carcinoma, Hepatocellular 7 Sarcoma 6 Rhabdomyosarcoma 6 Rhabdoid Tumor 6 Rectal Neoplasms 6 Osteosarcoma 6 Neuroectodermal Tumors, Primitive, Peripheral 6 Medulloblastoma 6 Histiocytosis, Langerhans-Cell 6 Glioma 6 Ependymoma 6 Pancreatic Neoplasms 5 Central Nervous System Neoplasms 5 Sarcoma, Ewing 4 Lung Neoplasms 4 Stomach Neoplasms 3 Ovarian Neoplasms 3 Esophageal Neoplasms 3 Colonic Neoplasms 3 Melanoma 2 Liver Neoplasms 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Xanthogranuloma, Juvenile 1 Uterine Cervical Neoplasms 1

Interventions

Endoscopy 15 Endoscopy, Digestive System 12 Biopsy 9 Endoscopic Mucosal Resection 8 Radiofrequency Ablation 7 Esomeprazole 7 Specimen Handling 6 Gastroscopy 6 Omeprazole 4 Aspirin 4 Proflavine 3 Narrow Band Imaging 3 Diagnostic Imaging 3 Breath Tests 3 YF 476 2 Proton Pump Inhibitors 2 Photochemotherapy 2 Microscopy, Confocal 2 Metformin 2 Lansoprazole 2 Itraconazole 2 Endoscopes 2 Dexlansoprazole 2 Cryotherapy 2 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2 rofecoxib 1 polyphenon E 1 omeprazole, sodium bicarbonate drug combination 1 obeticholic acid 1 gluconic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01209013 2012-05-08

Oedisse

Pinnacle Biologics Inc.

Phase 3 Withdrawn

Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡